
About Nexus BioPharma
Nexus BioPharma is a publicly listed company based in Montclair (United States) founded in 2007. Therapies for treating obesity and type 2 diabetes. The company has 1 employees. Nexus BioPharma offers products and services including Obesity Therapies and Diabetes Therapies. Its focus areas include Life Sciences, Metabolic Diseases and Drugs. Its legal entity is NEXUS BIOPHARMA INC. Its competitors include NGM Biopharmaceuticals, MannKind Corp and Rhythm Pharmaceuticals; 3 of its 3 listed competitors have raised funding.
Company details
Nexus BioPharma was founded in 2007 as a preclinical-stage biotechnology company located in Montclair, United States. Focus is placed on discovering and developing Fyn kinase inhibitors to activate the LKB1-AMPK metabolic pathway for treating obesity and type 2 diabetes. Operations involve collaboration with BioFocus DPI, a subsidiary of Charles River Laboratories, to advance these therapies.
- Headquarters Montclair, United States
- Employees 1
- Stage Public
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website nexusbiopharma.com
- Social X Facebook
- Legal Name Nexus Biopharma Inc
- Net Profit-$686.1 K (USD)40as on Feb 28, 2017
- Employee Count1
Products & Services of Nexus BioPharma
Nexus BioPharma offers a comprehensive portfolio of products and services, including Obesity Therapies and Diabetes Therapies.
Preclinical treatments targeting obesity through research and development.
Preclinical solutions for type 2 diabetes via innovative drug pipelines.
People of Nexus BioPharma
3 people are tracked at Nexus BioPharma (1 in leadership, 2 in board & advisors); the tracked headcount is 1.
| Name | Role | Group |
|---|---|---|
Warren C. Lau | President & CEO | Leadership |
Jeffrey Pessin | Chair | Board & advisors |
Dan Einhorn | Scientific Advisor | Board & advisors |
Complete people profiles for Nexus BioPharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of Nexus BioPharma
Nexus BioPharma has 3 listed competitors in our database, 3 of them funded. They include NGM Biopharmaceuticals, MannKind Corp and Rhythm Pharmaceuticals.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| ngmbio.com | 2007 | San Francisco, United States | $358.87M | 225 | Biologics are developed for cardio-metabolic and liver diseases. | |
| mannkindcorp.com | 1991 | Los Angeles, United States | $50M | 322 | Developer of small-molecule drugs | |
| rhythmtx.com | 2010 | Boston, United States | $84M | 115 | Developer of peptide therapeutics for the treatment of rare genetic deficiencies |
Detailed competitors of Nexus BioPharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Metabolic Diseases
3 companies that operate in the same segment as Nexus BioPharma (Metabolic Diseases) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Satiety induction through digestable gastric balloon introduced via a swallowed capsule | 2009 | Wellesley, Massachusetts, United States | USD 174.04 M | USD 32.11 M | 137 | |
Developer of peptide therapeutics for the treatment of rare genetic deficiencies | 2010 | Boston, Massachusetts, United States | USD 84 M | USD 189.76 M | 283 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Nexus BioPharma
Nexus BioPharma was founded in 2007.
Nexus BioPharma is headquartered in Montclair, United States. It is registered at Montclair, New Jersey, United States.
Nexus BioPharma has 1 employees.
Nexus BioPharma was founded in 2007 as a preclinical-stage biotechnology company located in Montclair, United States. Focus is placed on discovering and developing Fyn kinase inhibitors to activate the LKB1-AMPK metabolic pathway for treating obesity and type 2 diabetes. Operations involve collaboration with BioFocus DPI, a subsidiary of Charles River Laboratories, to advance these therapies.
Nexus BioPharma's top competitors include Rhythm Pharmaceuticals, MannKind Corp and NGM Biopharmaceuticals.
Nexus BioPharma offers Obesity Therapies and Diabetes Therapies.
Nexus BioPharma operates through Nexus Biopharma Inc.